...operations in Houston and Shanghai, raised a $42 million venture round led by BioTrack Capital and Yonghua Capital.Sensei...

...Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd., The Mark Foundation for Cancer Research and Yonghua Capital...

...which closed on Oct. 9. Fellow new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital...

...announced Oct. 9. Also participating were new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital...

...round, announced Tuesday. Also participating were new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital...

...and new investor Polaris Partners. New investors AbbVie Ventures, Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan), Yonghua Capital...

...and new investor Polaris Partners. New investors AbbVie Ventures, Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan), Yonghua Capital...

...Funds raised: $48 million Investors: Versant Ventures, Polaris Partners, AbbVie Ventures, Taiho Pharmaceutical Co. Ltd., Yonghua Capital...

...Lexington, Mass.) raised $25 million in a series B round on Dec. 21 led by Yonghua Capital...

...Biomedical LLC (Lexington, Mass.) raised $25 million in a series B round Thursday led by Yonghua Capital...